Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00996489 · ClinicalTrials.gov registry record · NA
This is a Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
A NA study, sponsored by Merz North America.
- Completed
- Registry status
- NA
- Development phase
- 459
- Enrollment target
NCT00996489: Completed NA study, sponsored by Merz North America.
NCT00996489 is a NA study that has completed, run by Merz North America. The registered enrollment target is 459 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00996489, a NA study, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- NA
- Development phase
- 459 participants
- Enrollment target
Study Summary
This is a post approval study of Coaptite® in the treatment of female urinary incontinence.
Primary Outcome
The Stamey grade classifies the severity stress incontinence and was calculated from the 4-day voiding diary using the four possible grades from 0-3. Grade 0: controlled urination, Grade 1: accidents with vigorous activity, for example, lifting weights, coughing, and sneezing, Grade 2: accidents with minimal activity, for example, walking and standing up, and Grade 3: accidents regardless of activity or position and that cannot be attributed to a specific activity. Higher the Stamey grade, the m
Interventions
- DEVICE Coaptite®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 459 participants |
| Start Date | 2008-01-08 |
| Est. Completion | 2015-11-02 |
| Phase | NA |
What the finished NCT00996489 record still lists
NCT00996489 is an interventional study that assigns participants to a tested intervention. The registered 459 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 1 intervention - of which Coaptite® is the first listed.
NCT00996489 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00996489 about?
NCT00996489 is a clinical study titled "This is a Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence". This is a post approval study of Coaptite® in the treatment of female urinary incontinence.
What is the current status of trial NCT00996489?
This trial is currently completed. It is a NA study. The enrollment target is 459 participants. The study started on 2008-01-08. Estimated completion is 2015-11-02.
What interventions are being tested in trial NCT00996489?
The interventions under investigation include: Coaptite® (DEVICE).
Who is sponsoring clinical trial NCT00996489?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00996489's enrollment target sits among peer trials
459 224th of 2000 higher than 1,777 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04452825 · 459 participants · NA
A New Psychotherapy Intervention for Older Cancer Patients
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- NCT03427736 · 460 participants
Anesthetics and Analgesics in Children
- NCT03819933 · 460 participants · NA
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI